Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jul;35(7):e15580.
doi: 10.1111/dth.15580. Epub 2022 May 26.

Therapeutic targets for vaccination in polyomavirus-driven Merkel cell carcinoma

Affiliations
Comment

Therapeutic targets for vaccination in polyomavirus-driven Merkel cell carcinoma

Tejas P Joshi et al. Dermatol Ther. 2022 Jul.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

REFERENCES

    1. Hernandez LE, Mohsin N, Yaghi M, Frech FS, Dreyfuss I, Nouri K. Merkel cell carcinoma: an updated review of pathogenesis, diagnosis, and treatment options. Dermatol Ther. 2021;29:e15292.
    1. Tabachnick-Cherny S, Pulliam T, Church C, Koelle DM, Nghiem P. Polyomavirus-driven Merkel cell carcinoma: prospects for therapeutic vaccine development. Mol Carcinog. 2020;59(7):807-821.
    1. Gehrcken L, Sauerer T, Schaft N, Dörrie J. T-cell responses in Merkel cell carcinoma: implications for improved immune checkpoint blockade and other therapeutic options. Int J Mol Sci. 2021;22(16):8679.
    1. Longino NV, Yang J, Iyer JG, et al. Human CD4+ T cells specific for Merkel cell polyomavirus localize to Merkel cell carcinomas and target a required oncogenic domain. Cancer Immunol Res. 2019;7(10):1727-1739.
    1. Jing L, Ott M, Church CD, et al. Prevalent and diverse intratumoral oncoprotein-specific CD8+ T cells within polyomavirus-driven Merkel cell carcinomas. Cancer Immunol Res. 2020;8(5):648-659.

LinkOut - more resources